SOLVISIA Trademark

Trademark Overview

On Thursday, March 28, 2002, a trademark application was filed for SOLVISIA with the United States Patent and Trademark Office. The USPTO has given the SOLVISIA trademark a serial number of 76389395. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 22, 2008. This trademark is owned by GENENTECH, INC.. The SOLVISIA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of immune diseases and disorders, angiogensis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
solvisia

General Information

Serial Number76389395
Word MarkSOLVISIA
Filing DateThursday, March 28, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 22, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2002

Trademark Statements

Goods and Servicespharmaceutical preparations for use in the treatment of immune diseases and disorders, angiogensis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Monday, December 22, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 22, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 13, 2008EXTENSION 5 GRANTED
Tuesday, May 13, 2008EXTENSION 5 FILED
Tuesday, May 13, 2008TEAS EXTENSION RECEIVED
Monday, November 19, 2007EXTENSION 4 GRANTED
Monday, November 19, 2007EXTENSION 4 FILED
Monday, November 19, 2007TEAS EXTENSION RECEIVED
Thursday, October 11, 2007ASSIGNED TO EXAMINER
Monday, May 21, 2007EXTENSION 3 GRANTED
Monday, May 21, 2007EXTENSION 3 FILED
Monday, May 21, 2007TEAS EXTENSION RECEIVED
Tuesday, November 21, 2006EXTENSION 2 GRANTED
Tuesday, November 21, 2006EXTENSION 2 FILED
Tuesday, November 21, 2006TEAS EXTENSION RECEIVED
Tuesday, September 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2006EXTENSION 1 GRANTED
Wednesday, April 26, 2006EXTENSION 1 FILED
Wednesday, April 26, 2006TEAS EXTENSION RECEIVED
Tuesday, November 22, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 4, 2005OPPOSITION TERMINATED NO. 999999
Thursday, August 4, 2005OPPOSITION DISMISSED NO. 999999
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 5, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 18, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2003OPPOSITION INSTITUTED NO. 999999
Tuesday, December 24, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 10, 2002PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2002NOTICE OF PUBLICATION
Monday, October 7, 2002PAPER RECEIVED
Wednesday, October 9, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 27, 2002PAPER RECEIVED
Monday, October 7, 2002EXAMINERS AMENDMENT MAILED
Thursday, October 3, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2002NON-FINAL ACTION MAILED
Friday, July 26, 2002ASSIGNED TO EXAMINER

Related Keywords

solvisia disorders diseases ocular inflammatory angiogensis preparations immune pharmaceutical treatment